创新医疗器械研发商精微视达完成超亿元新一轮融资

Group 1 - The core viewpoint of the article highlights that Jingwei Vision has completed a new round of financing exceeding 100 million yuan, aimed at advancing the research, production, clinical application, and global commercialization of its confocal endoscope products [2] - The company was founded in December 2014 and focuses on precision diagnosis and treatment of early-stage tumors, leveraging over 20 years of deep industry experience and multiple national key research projects [2] - Jingwei Vision has achieved significant technological advancements, obtaining several registration certificates for its confocal endoscopes and receiving national-level scientific and technological achievement certifications from the Ministry of Industry and Information Technology [2] Group 2 - Jingwei Vision has mastered key materials, core components, and complete systems for domestic confocal endoscopes, reducing reliance on imported technologies and establishing a self-sufficient, replicable, and scalable production chain [3] - The company has built the world's largest manufacturing center for confocal endoscopes, aiming to promote the localization and internationalization of this technology while exporting Chinese technical standards globally [3] - Future plans include deepening the integration of industry, academia, research, and clinical applications, focusing on iterative innovation of key technologies and optimizing production costs to achieve "domestic prices with international quality" for cell-level endoscopy technology [3]